Skip to main content

Störungen der Blutbildung (Anämien)

  • Chapter
Pharmakotherapie

Part of the book series: Springer-Lehrbuch ((SLB))

  • 2785 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Weiterführende Literatur

  • Andrews NC (1999) Disorders of iron metabolism. N Engl J Med 341: 1986–1995

    Article  PubMed  CAS  Google Scholar 

  • Andrews NC (2000) Iron metabolism: iron deficiency and iron overload. Annu Rev Genomics Hum Genet 1: 75–98

    Article  PubMed  CAS  Google Scholar 

  • Chertow GM, Mason PD, Vaage-Nilsen O, Ahlmén J (2006) Update on adverse drug events associated with parenteral iron. Nephrol Dial Transplant 21: 378–382

    Article  PubMed  CAS  Google Scholar 

  • Dinnendahl V, Fricke U (Hrsg) (2005) Arzneistoff-Profile. Basisinformation über arzneiliche Wirkstoffe. Gesamtwerk incl. 20. Erg.-Lieferung. Govi-Verlag Pharmazeutischer Verlag, Eschborn

    Google Scholar 

  • Dunn CJ, Markham A (1996) Epoetin beta. A review of its pharmacological properties and clinical use in the management of anaemia associated with chronic renal failure. Drugs 51: 299–318

    PubMed  CAS  Google Scholar 

  • Ferrario E, Ferrari L, Bidoli P, De Candis D, Del Vecchio M, De Dosso S, Buzzoni R, Bajetta E (2004) Treatment of cancer-related anemia with epoetin alfa: a review. Cancer Treatm Rev 30: 563–575

    Article  CAS  Google Scholar 

  • Fishbane S (2003) Safety in iron management. Am J Kidney Dis 41(Suppl 5): S8–S26

    Google Scholar 

  • Greer JP, Paraskevas F, Foerster J, Rodgers GM, Lukens JN, Glader BE (2003) Wintrobe’s Clinical Hematology, 11th Ed. Lippincott Williams & Wilkins, Philadelphia

    Google Scholar 

  • Goddnough LT, Brecher ME, Kanter MH, Aubuchon JP (1999) Transfusion medicine. N Engl J Med 340: 438–447

    Article  Google Scholar 

  • Heinrich H C (1986) Bioverfügbarkeit und therapeutischer Wert oraler Eisen-II-und Eisen-III-Präparate. Dtsch Apoth Ztg 126: 681–690

    Google Scholar 

  • Ibbotson T, Goa KL (2001) Darbepoetin alfa. Drugs 61:2097–2104; discussion 2105–2106.

    Article  PubMed  CAS  Google Scholar 

  • Leitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten: www.baek.de

    Google Scholar 

  • Markham A, Bryson H M (1995) Epoetin alfa. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in nonrenal applications. Drugs 49: 232–254

    PubMed  CAS  Google Scholar 

  • Müller-Eckhardt C (Hrsg) (2003) Transfusionsmedizin. Springer, Berlin

    Google Scholar 

  • Revised european best practice guidlines fort he management of anaemia in patients with chronic renal failure (2004) Nephrol Dial Transplant 19(2): ii16–ii31

    Google Scholar 

  • Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Hämotherapie): www.baek.de

    Google Scholar 

  • Thomas L, Thomas C, Heimpel H (2005) Neue Parameter zur Diagnostik von Eisenmangelzuständen. Dtsch Ärztebl 102: A580–A586

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Fricke, U., Gathof, B.S. (2007). Störungen der Blutbildung (Anämien). In: Lemmer, B., Brune, K. (eds) Pharmakotherapie. Springer-Lehrbuch. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-34181-9_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-34181-9_19

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-34180-2

  • Online ISBN: 978-3-540-34181-9

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics